330
Views
27
CrossRef citations to date
0
Altmetric
Review Article

Predictive markers in bladder cancer: Do we have molecular markers ready for clinical use?

, , &
Pages 291-304 | Received 03 Mar 2014, Accepted 29 May 2014, Published online: 18 Jul 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jialin Li, Yusheng Cheng, Guanghua Liu & Zhigang Ji. (2018) The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis. OncoTargets and Therapy 11, pages 3449-3459.
Read now

Articles from other publishers (26)

Francesca Sanguedolce, Magda Zanelli, Andrea Palicelli, Alessandra Bisagni, Maurizio Zizzo, Stefano Ascani, Maria Carmela Pedicillo, Angelo Cormio, Ugo Giovanni Falagario, Giuseppe Carrieri & Luigi Cormio. (2023) HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic, and Predictive Role. International Journal of Molecular Sciences 24:4, pages 3720.
Crossref
Francesca Sanguedolce, Magda Zanelli, Andrea Palicelli, Stefano Ascani, Maurizio Zizzo, Giorgia Cocco, Lars Björnebo, Anna Lantz, Matteo Landriscina, Vincenza Conteduca, Ugo Giovanni Falagario, Luigi Cormio & Giuseppe Carrieri. (2022) Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation. International Journal of Molecular Sciences 23:14, pages 7844.
Crossref
Lifu Huang, Xianjun Zhang, Feiping Li & Xiaohong Wang. (2022) MicroRNA-143-3p/TBX3 Axis Represses Malignant Cell Behaviors in Bladder Cancer. Computational and Mathematical Methods in Medicine 2022, pages 1-10.
Crossref
Ying-Hsu ChangPo-Hung LinChin-Chang ChenWen-Hui WengKai-Jie YuChung-Yi LiuChin-Hsuan HsiehTzu-Hsuan ChangI-Hung ShaoHung-Cheng KanCheng-Keng ChuangSee-Tong Pang. (2021) Gain of TPPP as a predictor of progression in patients with bladder cancer. Experimental and Therapeutic Medicine 22:5.
Crossref
Francesca Sanguedolce, Beppe Calò, Marco Chirico, Ugo Falagario, Gian Maria Busetto, Magda Zanelli, Alessandra Bisagni, Maurizio Zizzo, Stefano Ascani, Giuseppe Carrieri & Luigi Cormio. (2021) Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern. Journal of Pathology and Translational Medicine 55:4, pages 239-246.
Crossref
Francesca Sanguedolce, Beppe Calò, Vito Mancini, Magda Zanelli, Andrea Palicelli, Maurizio Zizzo, Stefano Ascani, Giuseppe Carrieri & Luigi Cormio. (2021) Non-Muscle Invasive Bladder Cancer with Variant Histology: Biological Features and Clinical Implications. Oncology 99:6, pages 345-358.
Crossref
Beppe Calò, Ugo Falagario, Francesca Sanguedolce, Alessandro Veccia, Marco Chirico, Emanuel Carvalho-Diaz, Paulo Mota, Estêvão Lima, Riccardo Autorino, Giuseppe Carrieri & Luigi Cormio. (2020) Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin. World Journal of Urology 38:12, pages 3161-3167.
Crossref
Anwei Liu, Yongping Xue, Fei Liu, Haoyuan Tan, Qiao Xiong, Shuxiong Zeng, Zhensheng Zhang, Xu Gao, Yinghao Sun & Chuanliang Xu. (2019) Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy. Cancer Biomarkers 26:3, pages 281-289.
Crossref
B. Calò, F. Sanguedolce, F. Fortunato, G. Stallone, N. d’Altilia, M. Chirico, U. Falagario, Vito Mancini, G. Carrieri & L. Cormio. (2019) The impact of age on intravesical instillation of Bacille Calmette–Guerin treatment in patients with high-grade T1 bladder cancer. Medicine 98:31, pages e16223.
Crossref
José Antonio March-Villalba, David Ramos-Soler, Pilar Soriano-Sarrió, David Hervás-Marín, Laura Martínez-García & José María Martínez-Jabaloyas. (2019) Immunohistochemical expression of Ki-67, Cyclin D1, p16INK4a, and Survivin as a predictive tool for recurrence and progression-free survival in papillary urothelial bladder cancer pTa / pT1 G2 (WHO 1973). Urologic Oncology: Seminars and Original Investigations 37:2, pages 158-165.
Crossref
Yinghui Yu, Hui Cao, Mengmeng Zhang, Fang Shi, Rui Wang & Xin Liu. (2018) Prognostic value of DNA methylation for bladder cancer. Clinica Chimica Acta 484, pages 207-212.
Crossref
Barbara Pardini, Francesca Cordero, Alessio Naccarati, Clara Viberti, Giovanni Birolo, Marco Oderda, Cornelia Di Gaetano, Maddalena Arigoni, Federica Martina, Raffaele A. Calogero, Carlotta Sacerdote, Paolo Gontero, Paolo Vineis & Giuseppe Matullo. (2018) microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes. Oncotarget 9:29, pages 20658-20669.
Crossref
Francesca Sanguedolce, Antonella Cormio, Paolo Massenio, Maria C. Pedicillo, Simona Cagiano, Francesca Fortunato, Beppe Calò, Giuseppe Di Fino, Giuseppe Carrieri, Pantaleo Bufo & Luigi Cormio. (2018) Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer. Journal of Cancer Research and Clinical Oncology 144:4, pages 637-644.
Crossref
Adrie van Bokhoven & M. Scott Lucia. 2018. Precision Molecular Pathology of Bladder Cancer. Precision Molecular Pathology of Bladder Cancer 103 116 .
Luigi Cormio, Vito Mancini, Beppe Calò, Oscar Selvaggio, Teobaldo Mazzilli, Francesca Sanguedolce & Giuseppe Carrieri. (2017) Asymptomatic solitary bladder plasmocytoma. Medicine 96:50, pages e9347.
Crossref
Yongpeng Xie, Xin Ma, Luyao Chen, Hongzhao Li, Liangyou Gu, Yu Gao, Yu Zhang, Xintao Li, Yang Fan, Jianwen Chen & Xu Zhang. (2017) MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis. Scientific Reports 7:1.
Crossref
Peggy Sekula, Susan Mallett, Douglas G. Altman & Willi Sauerbrei. (2017) Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles. PLOS ONE 12:6, pages e0178531.
Crossref
Luigi Cormio, Francesca Sanguedolce, Antonella Cormio, Paolo Massenio, Maria Carmela Pedicillo, Simona Cagiano, Giuseppe Calò, Vincenzo Pagliarulo, Giuseppe Carrieri & Pantaleo Bufo. (2017) Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer. Oncotarget 8:15, pages 25433-25441.
Crossref
Mercedes Ingelmo-Torres, Juan José Lozano, Laura Izquierdo, Albert Carrion, Meritxell Costa, Lidia Gómez, María José Ribal, Antonio Alcaraz & Lourdes Mengual. (2017) Urinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancer. Oncotarget 8:11, pages 18238-18247.
Crossref
Alana D. Ranzi, Jéssica N.L. da Silva, Túlio M. Graziottin, Nicola Annels & Claudia G. Bica. (2017) Immunohistochemistry Biomarkers in Nonmuscle Invasive Bladder Cancer. Applied Immunohistochemistry & Molecular Morphology 25:3, pages 178-183.
Crossref
Valentina Turinetto, Barbara Pardini, Alessandra Allione, Giovanni Fiorito, Clara Viberti, Simonetta Guarrera, Alessia Russo, Silvia Anglesio, Maria Grazia Ruo Redda, Giovanni Casetta, Giuseppina Cucchiarale, Paolo Destefanis, Marco Oderda, Paolo Gontero, Luigi Rolle, Bruno Frea, Paolo Vineis, Carlotta Sacerdote, Claudia Giachino & Giuseppe Matullo. (2016) H2AX phosphorylation level in peripheral blood mononuclear cells as an event-free survival predictor for bladder cancer. Molecular Carcinogenesis 55:11, pages 1833-1842.
Crossref
Xin Zhang, Yanli Zhang, Xinfeng Liu, Tong Liu, Peilong Li, Lutao Du, Yongmei Yang, Lili Wang & Chuanxin Wang. (2016) Nested quantitative PCR approach for urinary cell-free EZH2 mRNA and its potential clinical application in bladder cancer. International Journal of Cancer 139:8, pages 1830-1838.
Crossref
Rossana Critelli, Francesca Fasanelli, Marco Oderda, Silvia Polidoro, Manuela Bianca Assumma, Clara Viberti, Mirko Preto, Paolo Gontero, Giuseppina Cucchiarale, Irene Lurkin, Ellen C. Zwarthoff, Paolo Vineis, Carlotta Sacerdote, Giuseppe Matullo & Alessio Naccarati. (2016) Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up. Oncotarget 7:41, pages 67435-67448.
Crossref
Alex Kiselyov, Svetlana Bunimovich-Mendrazitsky & Vladimir Startsev. (2016) Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment. International Journal of Cancer 138:11, pages 2562-2569.
Crossref
Giuseppe Matullo, Alessio Naccarati & Barbara Pardini. (2016) MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids. International Journal of Cancer 138:10, pages 2334-2345.
Crossref
Maria Frantzi, Agnieszka Latosinska, Leif Flühe, Marie C. Hupe, Elena Critselis, Mario W. Kramer, Axel S. Merseburger, Harald Mischak & Antonia Vlahou. (2015) Developing proteomic biomarkers for bladder cancer: towards clinical application. Nature Reviews Urology 12:6, pages 317-330.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.